These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 29966615)

  • 1. Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets.
    Dewanjee S; Das S; Das AK; Bhattacharjee N; Dihingia A; Dua TK; Kalita J; Manna P
    Eur J Pharmacol; 2018 Aug; 833():472-523. PubMed ID: 29966615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciphering the Neuroprotective Role of Glucagon-like Peptide-1 Agonists in Diabetic Neuropathy: Current Perspective and Future Directions.
    Mehta K; Behl T; Kumar A; Uddin MS; Zengin G; Arora S
    Curr Protein Pept Sci; 2021; 22(1):4-18. PubMed ID: 33292149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic neuropathy: mechanisms to management.
    Edwards JL; Vincent AM; Cheng HT; Feldman EL
    Pharmacol Ther; 2008 Oct; 120(1):1-34. PubMed ID: 18616962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Concepts in the Molecular Mechanisms and Management of Diabetic Neuropathy by Pharmacotherapeutics and Natural Compounds.
    Shivam ; Gupta AK; Kumar S
    Cent Nerv Syst Agents Med Chem; 2024; 24(3):264-280. PubMed ID: 38551039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic peripheral neuropathy: current perspective and future directions.
    Singh R; Kishore L; Kaur N
    Pharmacol Res; 2014 Feb; 80():21-35. PubMed ID: 24373831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in understanding the role of oxidative stress in diabetic neuropathy.
    Shakeel M
    Diabetes Metab Syndr; 2015; 9(4):373-8. PubMed ID: 25470637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving Insights into the Pathophysiology of Diabetic Neuropathy: Implications of Malfunctioning Glia and Discovery of Novel Therapeutic Targets.
    Rahman MH; Jha MK; Suk K
    Curr Pharm Des; 2016; 22(6):738-57. PubMed ID: 26635266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Detailed Review of Molecular Pathways and Mechanisms Responsible for the Development and Aggravation of Neuropathy and Nephropathy in Diabetes.
    Chandra P; Sachan N; Saraswat N; Vyawahare N
    Curr Mol Pharmacol; 2024; 17(1):e280323215026. PubMed ID: 37018534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can diabetic neuropathy be prevented?
    Park TS; Park JH; Baek HS
    Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S53-6. PubMed ID: 15563981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effect of naringin by modulation of endogenous biomarkers in streptozotocin induced painful diabetic neuropathy.
    Kandhare AD; Raygude KS; Ghosh P; Ghule AE; Bodhankar SL
    Fitoterapia; 2012 Jun; 83(4):650-9. PubMed ID: 22343014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic Patients.
    Babizhayev MA; Strokov IA; Nosikov VV; Savel'yeva EL; Sitnikov VF; Yegorov YE; Lankin VZ
    Cell Biochem Biophys; 2015 Apr; 71(3):1425-43. PubMed ID: 25427889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetylcysteine inhibits hyperglycemia-induced oxidative stress and apoptosis markers in diabetic neuropathy.
    Kamboj SS; Vasishta RK; Sandhir R
    J Neurochem; 2010 Jan; 112(1):77-91. PubMed ID: 19840221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nrf2: a potential therapeutic target for diabetic neuropathy.
    Kumar A; Mittal R
    Inflammopharmacology; 2017 Aug; 25(4):393-402. PubMed ID: 28353124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistic insight of diabetic nephropathy and its pharmacotherapeutic targets: An update.
    Bhattacharjee N; Barma S; Konwar N; Dewanjee S; Manna P
    Eur J Pharmacol; 2016 Nov; 791():8-24. PubMed ID: 27568833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Horizons in Diabetic Neuropathies: An Updated Review on their Pathology, Diagnosis, Mechanism, Screening Techniques, Pharmacological, and Future Approaches.
    Aziz N; Dash B; Wal P; Kumari P; Joshi P; Wal A
    Curr Diabetes Rev; 2024; 20(6):e201023222416. PubMed ID: 37867268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herbal Remedies: A Boon for Diabetic Neuropathy.
    Tiwari R; Siddiqui MH; Mahmood T; Bagga P; Ahsan F; Shamim A
    J Diet Suppl; 2019; 16(4):470-490. PubMed ID: 29580105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ameliorative potential of rutin in combination with nimesulide in STZ model of diabetic neuropathy: targeting Nrf2/HO-1/NF-kB and COX signalling pathway.
    Mittal R; Kumar A; Singh DP; Bishnoi M; Nag TC
    Inflammopharmacology; 2018 Jun; 26(3):755-768. PubMed ID: 29094308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocotrienol attenuates oxidative-nitrosative stress and inflammatory cascade in experimental model of diabetic neuropathy.
    Kuhad A; Chopra K
    Neuropharmacology; 2009 Sep; 57(4):456-62. PubMed ID: 19555701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Insights of Plant Phytochemicals Against Diabetic Neuropathy.
    Balkrishna A; Pathak R; Bhatt S; Arya V
    Curr Diabetes Rev; 2023; 19(9):e250822207994. PubMed ID: 36028963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diabetic neuropathy].
    Kato Y; Kamiya H; Nakamura J
    Nihon Rinsho; 2015 Mar; 73(3):495-500. PubMed ID: 25812380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.